Prdm2-KO 基因敲除小鼠

1. Wei, Dong, Yiyuan, Chen, Qian, Liu, Yazhuo, Zhang, Hua, Gao. 2020. The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc. In Gene, 737, 144456. doi:10.1016/j.gene.2020.144456. https://pubmed.ncbi.nlm.nih.gov/32044406/

2. Gao, Hua, Wang, Fei, Lan, Xiaolei, Hong, Lichuan, Zhang, Yazhuo. 2015. Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas. In BMC cancer, 15, 272. doi:10.1186/s12885-015-1267-0. https://pubmed.ncbi.nlm.nih.gov/25884948/

3. van Toledo, David Efwm, Bleijenberg, Arne Gc, Venema, Andrea, IJspeert, Joep Eg, van Noesel, Carel Jm. . Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers. In The journal of pathology. Clinical research, 10, e348. doi:10.1002/cjp2.348. https://pubmed.ncbi.nlm.nih.gov/38380944/

4. Di Zazzo, Erika, Rienzo, Monica, Casamassimi, Amelia, Bifulco, Maurizio, Abbondanza, Ciro. 2023. Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation. In Journal of translational medicine, 21, 217. doi:10.1186/s12967-023-04066-x. https://pubmed.ncbi.nlm.nih.gov/36964555/

5. Cheedipudi, Sirisha, Gala, Hardik P, Puri, Deepika, Dhawan, Jyotsna. 2015. Identification of PRDM2 regulated genes in quiescent C2C12 myoblasts. In Genomics data, 6, 264-6. doi:10.1016/j.gdata.2015.10.004. https://pubmed.ncbi.nlm.nih.gov/26697392/